Japanese govt opts not to settle early in Iressa legal cases
This article was originally published in Scrip
Executive Summary
Like co-defendant AstraZeneca, Japan's government has decided not to accept a court-proposed early settlement of legal cases relating to side-effects attributed to the lung cancer drug Iressa (gefitinib).